No abstract available
Keywords:
COVID-19; glomerular disease; immunosuppression; kidney diseases; severe acute respiratory syndrome coronavirus 2.
MeSH terms
-
Betacoronavirus / immunology*
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Testing
-
Clinical Laboratory Techniques
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / immunology*
-
Coronavirus Infections / virology
-
Host-Pathogen Interactions
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / administration & dosage*
-
Immunosuppressive Agents / adverse effects
-
Nephrosis, Lipoid / diagnosis
-
Nephrosis, Lipoid / drug therapy*
-
Nephrosis, Lipoid / immunology
-
Pandemics
-
Patient Safety
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / immunology*
-
Pneumonia, Viral / virology
-
Predictive Value of Tests
-
Reagent Strips
-
Recurrence
-
Risk Assessment
-
Risk Factors
-
Rituximab / administration & dosage*
-
Rituximab / adverse effects
-
SARS-CoV-2
-
Urinalysis / instrumentation
Substances
-
Immunosuppressive Agents
-
Reagent Strips
-
Rituximab